Supernus Pharmaceuticals
SUPN
SUPN
293 hedge funds and large institutions have $1.87B invested in Supernus Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 124 increasing their positions, 83 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.29% more ownership
Funds ownership: 105.9% → 106.19% (+0.29%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less capital invested
Capital invested by funds: $1.94B → $1.87B (-$62.4M)
Holders
293
Holding in Top 10
2
Calls
$677K
Puts
$13K
Top Buyers
| 1 | +$24.8M | |
| 2 | +$22.3M | |
| 3 | +$8.93M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.05M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$4.22M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$11.5M | |
| 3 | -$10.1M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$8.96M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$7.02M |